The Asia - Pacific Respiratory Devices market is anticipated to grow at more than 8.53% CAGR from 2026 to 2031.

  • Historical Period: 2020-2024
  • Base Year: 2025
  • Forecast Period: 2026-2031
  • CAGR (2026-2031): 8.53
  • Largest Market: China
  • Fastest Market: India
  • Format: PDF & Excel
Featured Companies
  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • More...

Market Analysis

The respiratory devices sector in the Asia Pacific region has rapidly progressed within the framework, propelled by quick urban growth, heightened air pollution, and better access to healthcare services in both developing and developed nations. The main aim and focus of respiratory devices in this region is to manage a wide variety of respiratory issues, including chronic conditions and complications arising from infections. In the past, the market shifted from depending on basic oxygen delivery methods and basic nebulizers to more sophisticated ventilatory support systems, CPAP and BiPAP machines, as well as portable oxygen concentrators. This change was significantly impacted by the increasing rates of asthma, tuberculosis, chronic obstructive pulmonary disease COPD, and respiratory infections, particularly in thickly populated urban areas. From a technical standpoint, respiratory devices are crafted to help, track, or improve lung function by enhancing airflow, oxygen delivery, and medication administration, thus aiding both immediate and long-term respiratory care. In practical scenarios, these devices are essential in lessening the severity of illnesses, enhancing survival rates, and boosting patients' quality of life in both hospital and home care environments. Efforts in research and development by both local and international manufacturers have focused on creating affordable, portable, and user-friendly devices suited to local demands. Advances in compact ventilators, battery-powered oxygen concentrators, and smart respiratory technologies have made these tools more accessible and widely used. The regulatory environment, overseen by entities like CDSCO, PMDA, and NMPA, guarantees adherence to safety and quality norms, bolstering patient confidence and facilitating sustainable market growth throughout the Asia Pacific area. According to the research report, " Asia - Pacific Respiratory Devices Market Research Report, 2031," published by Actual Market Research, the Asia - Pacific Respiratory Devices market is anticipated to grow at more than 8.53% CAGR from 2026 to 2031. This swift growth is driven by a large, increasing patient base, heightened awareness regarding respiratory health, and ongoing enhancements in healthcare systems throughout nations like China, India, Japan, and Southeast Asian countries.

Recent trends feature the growth of domestic manufacturing, which lowers reliance on imports and improves the affordability of respiratory devices. Governments in the region are actively backing local production with policy incentives and healthcare investment initiatives. Moreover, the use of tele-respiratory care and remote monitoring solutions is on the rise, particularly in urban and semi-urban locales, enhancing patients' access to specialist care. Major market participants, including Nihon Kohden, Yuwell, Mindray, and local branches of international firms, significantly contribute by providing a diverse array of ventilators, monitoring systems, oxygen therapy equipment, and home respiratory care solutions. These businesses prioritize competitive pricing, technological advancements, and regional customization to bolster their presence in the market. Opportunities in the market are further propelled by upgraded hospital facilities, increased healthcare spending, and initiatives led by the government aimed at preventing and managing respiratory illnesses. These elements place the Asia Pacific region as the most vibrant and rapidly growing sector in the respiratory devices market. .

What's Inside a Actual Market Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample
Report Sample Preview

Market Dynamic

Market Drivers

• Significant and expanding burden of respiratory illnesses: The Asia Pacific region has a large population suffering from respiratory conditions including asthma, COPD, tuberculosis, and complications arising post-infection. The rapid growth of cities and industries has led to increased air pollution, negatively impacting respiratory health. The high rates of smoking in some areas also elevate the occurrence of such diseases. High population density facilitates the rapid transmission of respiratory illnesses. Governments are placing more emphasis on early detection and treatment initiatives. The rising awareness is leading to a larger pool of individuals receiving treatment. These elements collectively enhance the demand for respiratory devices.

• Enhancements in healthcare systems and accessibility: Numerous countries in the Asia Pacific region are dedicating significant resources to develop healthcare systems. The growth of hospitals, intensive care units, and diagnostic facilities encourages the use of respiratory devices. Public funding for health services is increasing, especially in India and China. The private healthcare sector is also expanding quickly. More people are gaining access to medical insurance coverage. Improved availability allows for earlier intervention and ongoing management of respiratory conditions. This continues to foster market growth. Market Challenges

• Price sensitivity and financial barriers: A significant part of the population is very conscious of costs. Advanced respiratory equipment is often beyond reach without government assistance. Limited reimbursement options in certain nations hinder wider acceptance. Public healthcare facilities often face financial limitations. Patients might postpone treatment due to financial worries. Cheaper alternatives sometimes sacrifice quality. Cost remains a major challenge in the market.

• Varied regulations among countries: The Asia Pacific region boasts a diverse range of regulations across its countries. Producers need to adhere to numerous approval procedures. This can prolong time to market and raise compliance expenses. Smaller companies may find it difficult to enter the market. Regulatory changes can hinder the timely launch of products. The lack of uniformity complicates scalability. These factors make regional expansion strategies challenging. Market Trends

• Increase in portable and affordable respiratory equipment: Manufacturers are concentrating on creating cost-effective and portable respiratory devices. Small oxygen concentrators and ventilators are becoming more favored. These devices are tailored for use in rural and semi-urban areas. Battery-powered systems are essential for regions with unstable power. User-friendliness is a key priority. Inexpensive innovations are a notable trend. This encourages broader acceptance.

• Growth in tele-respiratory and digital health initiatives:The adoption of telemedicine is swiftly rising in the Asia Pacific area. Remote monitoring of respiratory conditions enhances access to specialized healthcare. Digital platforms facilitate tracking of diseases and treatment adherence. Smartphone applications are being widely embraced. Governments are promoting the integration of digital health solutions. This trend encourages respiratory care at home. Technology is transforming the way care is delivered.
Make this report your own

We're excited to discuss your needs and our solutions. Let's schedule a call.

Manmayi Raval
Manmayi Raval

Analyst

Segmentation

By Product Type Therapeutic Devices
Monitoring Devices
Diagnostic Devices
Consumables and Accessories
By Disease Indication Chronic Obstructive Pulmonary disease (COPD)
Sleep Apnea
Asthma
Infectious Diseases
Other disease Indications (Respiratory Distress Syndrome, cystic Fibrosis)
By End User Hospitals
Ambulatory Care Centers (ACCs)
Home care Settings
Other End User
Asia-Pacific North America
Europe
Asia-Pacific
South America
MEA



Therapeutic devices lead the market due to the significant prevalence of chronic and acute respiratory illnesses, large numbers of affected individuals, and a strong need for treatment-specific solutions in both hospitals and homecare environments.

In the Asia Pacific region, therapeutic respiratory devices have become the most prominent product category in the respiratory devices market, primarily because it bears one of the highest levels of respiratory health issues ly, necessitating urgent, intervention-focused treatment. The rapid growth of cities, environmental pollution, exposure to biomass fuels, and the high rates of smoking in countries such as China, India, and various Southeast Asian countries have notably raised the number of cases of COPD, asthma, and acute respiratory infections. Such ailments require ongoing therapeutic assistance via inhalers, nebulizers, oxygen concentrators, ventilators, and positive airway pressure devices. Furthermore, the extensive and aging population in the Asia Pacific escalates the demand for these products, confirming therapeutic devices as crucial for long-term disease management as well as emergency procedures. Public hospitals and local healthcare facilities prioritize these therapeutic tools, especially in populous areas where outbreaks of diseases and seasonal respiratory conditions frequently occur. Moreover, many nations in the region are working to enhance access to affordable healthcare, leading to an increased acquisition of budget-friendly therapeutic devices to satisfy basic treatment requirements. In contrast to monitoring instruments, which often serve a supportive role, therapeutic devices directly affect survival rates and alleviate symptoms, making them absolutely vital. The rise in home healthcare facilitated by portable oxygen concentrators and nebulizers also boosts their market presence. Government healthcare programs, expanded insurance plans, and local production of economical therapeutic devices play a significant role in maintaining their leading position. The critical medical need, population scale, and treatment-focused healthcare objectives establish therapeutic devices as the predominant product category in the Asia Pacific respiratory devices market.

COPD arises from prevalent air pollution, widespread smoking habits, biomass fuel exposure, and a significant aging demographic needing long-term respiratory care.

Chronic Obstructive Pulmonary Disease COPD stands out as the most significant disease representation in the Asia Pacific respiratory devices market due to the area's exceptionally high and persistent respiratory illness rates. The rapid growth of industries and urban areas has resulted in severe air quality issues in key economies such as China and India, which has greatly raised the rates of COPD. In numerous rural and semi-urban locations, prolonged usage of biomass fuels for cooking and heating continues to pose a major risk, especially for women. Elevated smoking incidence in many Asia Pacific nations worsens the prevalence of the disease. COPD is an advancing and irreversible illness that demands ongoing treatment, which boosts the sustained need for respiratory therapeutic devices like inhalers, nebulizers, oxygen concentrators, and non-invasive ventilation apparatuses. The region's large and older population increases demand significantly, as the occurrence of the disease escalates with age. Public healthcare institutions and local health centers emphasize COPD treatment to lower mortality rates and reduce frequent admissions to hospitals. Furthermore, enhancing healthcare access, government-led screening initiatives, and growing awareness of the disease are broadening the base of diagnosed patients. Exacerbations of COPD commonly necessitate emergency respiratory assistance, further emphasizing the use of devices in both acute and long-lasting care environments. The expansion of affordable, locally produced respiratory equipment has also enhanced accessibility. In combination, environmental hazards, lifestyle elements, demographic size, and a need for ongoing treatment establish COPD as the primary disease indication in the Asia Pacific market for respiratory devices.

Hospitals lead the Asia Pacific respiratory devices market because of high patient numbers for acute and infectious respiratory issues, along with advanced respiratory care infrastructure concentrated in hospitals.

The By End User Hospitals category is the largest in the Asia Pacific respiratory devices market since hospitals act as main and most reachable locations for diagnosing, treating, and providing critical care for respiratory illnesses in the region. Countries in the Asia Pacific deal with a significant incidence of both acute and chronic respiratory illnesses, such as asthma, COPD, tuberculosis, pneumonia, and complications after infections, often needing treatment that takes place in hospitals. Public and private hospitals handle most emergency respiratory situations and accommodate intensive care units ICUs furnished with ventilators, oxygen therapy units, and sophisticated respiratory monitoring tools. In many developing countries within the region, specialized respiratory care continues to be mainly offered in hospitals rather than in outpatient or home care environments. Investments from the government in enhancing hospital infrastructure, especially in China, India, and Southeast Asia, have improved hospitals’ abilities to provide respiratory care. Hospitals also play a vital part in controlling respiratory outbreaks and public health crises, which enhances the demand for respiratory devices. Furthermore, skilled healthcare workers and pulmonologists primarily work within hospital settings, facilitating the effective use of complex devices. The combination of high patient volumes, centralized care delivery, and comprehensive respiratory infrastructure positions hospitals as the largest end-user segment in the Asia Pacific respiratory devices market.

Market Regional Insights


China is at the forefront of the respiratory device market because of its extensive manufacturing capabilities, government backing, and swift integration of advanced medical technologies.

China's leadership in the respiratory device sector stems from a mix of effective government strategies, a strong manufacturing framework, and a fast-growing demand for healthcare prompted by its large population and the increased incidence of respiratory conditions. The government has made significant investments in healthcare, focusing on fostering innovation, encouraging domestic production, and adopting new technologies. This has led to reduced production expenses and improved access to respiratory devices. Moreover, the country enjoys a vast industrial base that can mass-produce equipment like ventilators, oxygen concentrators, nebulizers, and CPAP machines at affordable costs, allowing it to efficiently serve both local and international markets. In , heightened awareness about respiratory health, along with the growing rates of chronic illnesses such as COPD and asthma, and the effects of urban pollution, have driven up local consumption of these devices. Also, China has emerged as a major exporter by utilizing trade agreements, efficient supply chains, and partnerships in technology to reach markets outside its borders. The accelerated growth of the respiratory device industry, as there was a spike in demand for ventilators and oxygen therapy equipment, leading Chinese manufacturers to rapidly increase production to satisfy this exceptional need. with strong investment in research and development, collaborations between private companies and government entities, and advancements like smart ventilators and mobile oxygen concentrators, China has upheld its competitive advantage. All these elements play a crucial role in establishing China as a leader in the respiratory device market, making it both a key producer and an essential innovator in this vital healthcare area.

Companies Mentioned

  • 1 . Koninklijke Philips
  • 2 . Medtronic plc
  • 3 . Masimo
  • 4 . Cardinal Health, Inc.
  • 5 . Medline Industries, Inc.
  • 6 . Marico Limited
  • 7 . Stryker corporation
  • 8 . Siemens AG
  • 9 . GE Healthcare
  • 10 . Vapotherm Inc.
  • 11 . ResMed
  • 12 . Fisher & Paykel Healthcare Corporation Limited
  • 13 . Dragerwerk AG & Co. KGaA
  • 14 . Juki Corporation
  • 15 . Invacare Corporation
  • 16 . Nidek Medical Products Inc.
  • 17 . Teijin Limited
  • 18 . Besco Medical Limited

Table of Contents

  • Table 1: Influencing Factors for Respiratory Devices Market, 2025
  • Table 2: Top 10 Counties Economic Snapshot 2024
  • Table 3: Economic Snapshot of Other Prominent Countries 2022
  • Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
  • Table 5: Asia-Pacific Respiratory Devices Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
  • Table 6: Asia-Pacific Respiratory Devices Market Size and Forecast, By Disease Indication (2020 to 2031F) (In USD Billion)
  • Table 7: Asia-Pacific Respiratory Devices Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
  • Table 8: China Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 9: China Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 10: Japan Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 11: Japan Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 12: India Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 13: India Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 14: Australia Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 15: Australia Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 16: South Korea Respiratory Devices Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
  • Table 17: South Korea Respiratory Devices Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
  • Table 18: Competitive Dashboard of top 5 players, 2025

  • Figure 1: Asia-Pacific Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 2: Asia-Pacific Respiratory Devices Market Share By Country (2025)
  • Figure 3: China Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 4: Japan Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 5: India Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 6: Australia Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 7: South Korea Respiratory Devices Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
  • Figure 8: Porter's Five Forces of Global Respiratory Devices Market

Market Research FAQs

Several factors are contributing to the growth of this market, including Rising Respiratory Diseases, Aging Population, Technological Advancements and many more.
The market is expected to continue its growth trajectory due to increasing respiratory diseases, the aging population, and technological advancements. Telemedicine and remote patient monitoring are likely to become more prevalent, enhancing patient care and accessibility to respiratory services.
Some key trends in the market include the increasing adoption of portable and wearable respiratory devices, the integration of smart technologies for remote monitoring, and the development of customized treatment plans for patients with respiratory conditions.
Countries like China and India, with their large populations and growing healthcare infrastructure, are significant contributors to the growth of the market. Japan, South Korea, and Australia also play vital roles in the regional market.
Telemedicine and telehealth are enabling remote monitoring of patients with respiratory conditions. Patients can receive guidance and adjustments to their treatment plans without the need for frequent in-person visits, enhancing accessibility to care.
The increasing need is due to the higher occurrence of respiratory illnesses like asthma and COPD, worsening air quality, an aging demographic, and a greater focus on respiratory wellness.
The most commonly used devices include inhalers, nebulizers, and ventilators. Inhalers are popular for their simplicity, while hospitals are using more ventilators for critical situations.
The market faces challenges such as limited healthcare availability in countryside regions, expensive advanced equipment, insufficient knowledge about correct usage, and regulatory difficulties.
China, India, Japan, and South Korea offer the best growth prospects due to their large population sizes, rising disease rates, and enhancements in healthcare systems.

Why Actual Market Research?

  • Our seasoned industry experts bring diverse sector experience, tailoring methodologies to your unique challenges.
  • Leveraging advanced technology and time-tested methods ensures accurate and forward-thinking insights.
  • Operating globally with a local touch, our research spans borders for a comprehensive view of international markets.
  • Timely and actionable insights empower swift, informed decision-making in dynamic market landscapes.
  • We foster strong client relationships based on trust, transparency, and collaboration.
  • Our dedicated team adapts and evolves strategies to meet your evolving needs.
  • Upholding the highest standards of ethics and data security, we ensure confidentiality and integrity throughout the research process.

How client has rates us?

Requirement Gathering & Methodology 92%
Data Collection Techniques 97%
Our Research Team & Data Sourcing 93%
Data Science & Analytical Tools 81%
Data Visualization & Presentation Skills 86%
Project/ Report Delivery & After Sales Services 88%

Related Tags